Why the study?
Glucose-dependent insulinotropic polypeptide has been proposed to exert insulin-independent effects on lipid and bone metabolism, but its physiological effects in type 1 diabetes required investigation.
Does a 6-day subcutaneous GIP infusion affect lipid metabolism, fat distribution, and bone homeostasis in men with type 1 diabetes?
Does a 6-day subcutaneous GIP infusion affect lipid metabolism, fat distribution, and bone homeostasis in men with type 1 diabetes?
A 6-day GIP infusion in men with type 1 diabetes transiently decreased bone resorption and increased hepatic fat content and BAT activity, without affecting WAT transcriptomics.
Answers are grounded in this paper and cite their sources.
GIP infusion may alter hepatic fat and BAT thermogenesis in T1D; leaves open clinical relevance pending confirmatory trials.
CONTEXT: Glucose-dependent insulinotropic polypeptide (GIP) has been proposed to exert insulin-independent effects on lipid and bone metabolism. OBJECTIVE: We investigated the effects of a 6-day subcutaneous GIP infusion on circulating lipids, white adipose tissue (WAT), brown adipose tissue (BAT), hepatic fat content, inflammatory markers, respiratory exchange ratio (RER), and bone homeostasis in patients with type 1 diabetes. METHODS: In a randomized, placebo-controlled, double-blind, crossover study, 20 men with type 1 diabetes underwent a 6-day continuous subcutaneous infusion with GIP (6 pmol/kg/min) and placebo (saline), with an interposed 7-day washout period. RESULTS: During GIP infusion, participants (26 ± 8 years [mean ± SD]; BMI 23.8 ± 1.8 kg/m2; glycated hemoglobin A1c 51 ± 10 mmol/mol [6.8 ± 3.1%]) experienced transiently increased circulating concentrations of nonesterified fatty acid (NEFA) (P = 0.0005), decreased RER (P = 0.009), indication of increased fatty acid β-oxidation, and decreased levels of the bone resorption marker C-terminal telopeptide (P = 0.000072) compared with placebo. After 6 days of GIP infusion, hepatic fat content was increased by 12.6% (P = 0.007) and supraclavicular skin temperature, a surrogate indicator of BAT activity, was increased by 0.29 °C (P < 0.000001) compared with placebo infusion. WAT transcriptomic profile as well as circulating lipid species, proteome, markers of inflammation, and bone homeostasis were unaffected. CONCLUSION: Six days of subcutaneous GIP infusion in men with type 1 diabetes transiently decreased bone resorption and increased NEFA and β-oxidation. Further, hepatic fat content, and supraclavicular skin temperature were increased without affecting WAT transcriptomics, the circulating proteome, lipids, or inflammatory markers.
No takes yet. Share an insight, caveat, or question.
HEIMBÜRGER et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: